يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Oriol Gasch"', وقت الاستعلام: 1.14s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona

    وصف الملف: application/pdf

  4. 4

    المصدر: Infectious Diseases (London, England)
    article-version (VoR) Version of Record

  5. 5

    المساهمون: Institut Català de la Salut, [Bergas A] Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain. [Albasanz-Puig A] Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. [Fernández-Cruz A] Clinical Microbiology and Infectious Diseases Department, General University Hospital Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Infectious Disease Unit, Internal Medicine Department, Puerta de Hierro Hospital, Madrid, Spain. [Machado M] Clinical Microbiology and Infectious Diseases Department, General University Hospital Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. [Novo A] Hematology Department, Son Espases Hospital, Mallorca, Spain. [van Duin D] Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Aguilar-Company J] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Microbiology (medical), Tazobactam, Neutropenia, ceftolozane/tazobactam, Physiology, multidrug-resistant, Pseudomonas aeruginosa, bacteremia, bloodstream infection, hematologic malignancy, neutropenia, Anti-Bacterial Agents, Cephalosporins, Cohort Studies, Drug Resistance, Multiple, Bacterial, Humans, Microbial Sensitivity Tests, Pneumonia, Pseudomonas Infections, Sepsis, Drug Resistance, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos [COMPUESTOS QUÍMICOS Y DROGAS], Hematologia oncològica, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Genetics, Medicaments antibacterians - Ús terapèutic, Other subheadings::/therapeutic use [Other subheadings], neoplasias::neoplasias por localización::neoplasias hematológicas [ENFERMEDADES], General Immunology and Microbiology, Ecology, Otros calificadores::/uso terapéutico [Otros calificadores], Bacterial, Cell Biology, Neoplasms::Neoplasms by Site::Hematologic Neoplasms [DISEASES], infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias gramnegativas::infecciones por Pseudomonas [ENFERMEDADES], Infectious Diseases, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [CHEMICALS AND DRUGS], Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Pseudomonas Infections [DISEASES], Multiple, Malalties bacterianes gramnegatives - Tractament

    وصف الملف: application/pdf

  6. 6

    المصدر: The Journal of infection. 83(5)

  7. 7

    المساهمون: Ministerio de Ciencia, Innovación y Universidades (España), Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad (España), European Commission, Spanish Clinical Research Network, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Institut Català de la Salut, [Pujol M, Shaw E] Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biomèdiques de Bellvitge, University of Barcelona, Barcelona, Spain. [Miró JM] Department of Infectious Diseases, Hospital Clinic, Institut d’Investigacions Biomèdiques Agust Pi i Sunyer, University of Barcelona, Barcelona, Spain. [Aguado JM, San-Juan R] Department of Infectious Diseases, Hospital Universitario 12 Octubre, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain. [Puig-Asensio M, Pigrau C] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Repositorio Abierto de la UdL
    Universitad de Lleida
    Digital.CSIC. Repositorio Institucional del CSIC
    instname
    CLINICAL INFECTIOUS DISEASES
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Universidad Europea (UEM)
    Scientia

    مصطلحات موضوعية: 0301 basic medicine, Bacteremia, MRSA, medicine.disease_cause, Other subheadings::Other subheadings::/drug therapy [Other subheadings], terapéutica::tratamiento combinado [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Infeccions per estafilococs - Tractament, law.invention, Bacterièmia, 0302 clinical medicine, Randomized controlled trial, law, Clinical endpoint, polycyclic compounds, Medicaments antibacterians - Ús terapèutic, 030212 general & internal medicine, Endocarditis, Bacterèmia, Fosfomicina, Staphylococcal Infections, infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas::infecciones estafilocócicas [ENFERMEDADES], Anti-Bacterial Agents, Clinical trial, Infectious Diseases, Treatment Outcome, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [CHEMICALS AND DRUGS], lipids (amino acids, peptides, and proteins), Estafilococ aureus resistent a la meticil·lina, medicine.drug, Microbiology (medical), Adult, medicine.medical_specialty, 030106 microbiology, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Fosfomycin, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos [COMPUESTOS QUÍMICOS Y DROGAS], Estafilococo aureus resistente a la meticilina, 03 medical and health sciences, Daptomycin, Internal medicine, medicine, Humans, Adverse effect, business.industry, biochemical phenomena, metabolism, and nutrition, medicine.disease, bacterial infections and mycoses, Methicillin-resistant Staphylococcus aureus, Therapeutics::Combined Modality Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], carbohydrates (lipids), Daptomicina, Bacteriemia, Methicillin-resistant staphylococcus aureus, Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Staphylococcal Infections [DISEASES], business

    وصف الملف: application/pdf

  8. 8

    المساهمون: Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (España), Ministerio de Ciencia, Innovación y Universidades (España), Red Española de Investigación en Patología Infecciosa, European Commission, Spanish Network for Research in Infectious Diseases/Enterobacter spp. Bacteriemia Project Group, [Álvarez-Marín,R, Lepe,JA, Martín-Gandul,C, Jiménez-Mejías,ME] Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Infectious Diseases Research Group, Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC/Virgen del Rocío University Hospital, Seville, Spain. [Gasch-Blasi,O] Infectious Diseases Service, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (l3PT), Sabadell, Spain, Spanish Network for Research in Infectious Diseases. [Rodríguez-Martínez,JM, Pascual-Hernández,Á] Department of Microbiology, Virgen Macarena University Hospital, Seville, Spain, Infectious Diseases Research Group, Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC, Seville, Spain. [Calvo-Montes,J, Cano-García,ME, Martínez-Martínez,L] Department of Microbiology, Marqués de Valdecilla University Hospital – IDIVAL, Santander, Spain. [Lara-Contreras,R, Torre-Cisneros,J] Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Clinical Unit of Infectious Diseases, Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain. [Tubau-Quintano,F] Department of Microbiology, University Hospital of Bellvitge, Barcelona, Spain, CIBER of Respiratory Diseases (CIBERes), Instituto de Salud Carlos III, Madrid, Spain. [Rodríguez-López,F] Department of Microbiology, Reina Sofía University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Córdoba, Spain. [Rodríguez-Baño,J] Department of Medicine, Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Virgen Macarena University Hospital, Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC, Seville, Spain. [Pujol-Rojo,M] Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Català de la Salut (ICS-HUB), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Barcelona, Spain. [Martínez-Martínez,L] Department of Molecular Biology, University of Cantabria, Santander, Spain. [Martínez-Martínez,L] Department of Microbiology, Reina Sofía University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Córdoba, Spain., This work was supported by the Instituto Carlos III [grant PS09/00916], Ministerio de Ciencia e Innovación, the Plan Nacional I+D+i 2013–2016 and Instituto Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases [REIPI, RD16/0016/0001, RD16/0016/0005, RD16/0016/0007, RD16/0016/0008, RD16/0016/0009], co-financed by the European Regional Development Fund ‘A way to achieve Europe’, Operative program Intelligent Growth 2014–2020.

    المصدر: Journal of Global Antimicrobial Resistance, Vol 25, Iss, Pp 351-358 (2021)
    Digital.CSIC. Repositorio Institucional del CSIC
    instname

    مصطلحات موضوعية: Quinolone resistance mechanism, 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies [Medical Subject Headings], Case–control study, medicine.drug_class, 030106 microbiology, Immunology, Antibiotics, Bacteremia, Enterobacter aerogenes, Microbiology, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Klebsiella aerogenes, Genotype, Enterobacter cloacae, medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Enterobacter::Enterobacter aerogenes [Medical Subject Headings], Estudios de casos y controles, biology, business.industry, Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Bacteremia [Medical Subject Headings], Incidence (epidemiology), Case-control study, Enterobacteriaceae Infections, bacterial infections and mycoses, biology.organism_classification, QR1-502, Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Enterobacteriaceae Infections [Medical Subject Headings], Multiple drug resistance, Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Enterobacter::Enterobacter cloacae [Medical Subject Headings], Bacteriemia, Bacteraemia, business

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

  9. 9

    المساهمون: Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades (España), Red Española de Investigación en Patología Infecciosa, European Commission

    المصدر: Digital.CSIC. Repositorio Institucional del CSIC
    instname

  10. 10

    المساهمون: University of Zurich, Moreno, A, Ministerio de Sanidad y Consumo (España), Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (España), Institut d'Investigacions Biomèdiques August Pi i Sunyer, European Society of Clinical Microbiology and Infectious Diseases, Federation of European Microbiological Societies

    المصدر: Digital.CSIC. Repositorio Institucional del CSIC
    instname